Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000798174 | SCV000937775 | pathogenic | Charcot-Marie-Tooth disease type 4A | 2018-12-13 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has been reported to affect GDAP1 protein function via a dominant-negative or gain-of-function mechanism (PMID: 19782751, 23628762, 21890626, 18021315, 28220846). This variant has been observed to be de novo in an individual affected with Charcot-Marie-Tooth disease (PMID: 15805163), which is consistent with an autosomal dominant pattern of inheritance. ClinVar contains an entry for this variant (Variation ID: 4199). This variant is not present in population databases (ExAC no frequency). This sequence change replaces threonine with proline at codon 157 of the GDAP1 protein (p.Thr157Pro). The threonine residue is moderately conserved and there is a small physicochemical difference between threonine and proline. |
OMIM | RCV000004419 | SCV000024592 | pathogenic | Charcot-Marie-Tooth disease axonal type 2K | 2005-04-01 | no assertion criteria provided | literature only | |
Gene |
RCV001533514 | SCV001750196 | not provided | Charcot-Marie-Tooth disease | no assertion provided | literature only | ||
Inherited Neuropathy Consortium Ii, |
RCV000798174 | SCV004174628 | uncertain significance | Charcot-Marie-Tooth disease type 4A | 2016-01-06 | no assertion criteria provided | literature only |